NPI Details
DR. Enrico Guy Jones, M.D. is a pain medicine pain medicine in Greensboro, NC with 31 years of experience. The provider is pain Medicine is a primary medical specialty based on a distinct body of knowledge and a well-defined scope of clinical practice that is founded on science, research and education. It is concerned with the study of pain, the prevention of pain, and the evaluation, treatment, and rehabilitation of persons in pain. A comprehensive evaluation incorporates the physical, psychological, cognitive and socio-cultural contributions to pain. The treatment protocol may include pharmacological, invasive, behavioral, cognitive, rehabilitative and complementary strategies provided in a concurrent focused and patient specific manner. The pain medicine physician often serves the patient as a frontline physician regarding their pain, but also may serve as a consultant to other physicians, direct an interdisciplinary/multidisciplinary treatment team, conduct research, or advocate for the patient's pain care with public and private agencies. The Pain Medicine physician may work in variety of settings including office, clinic, hospital, university, or governmental/public agencies. DR. Enrico Guy Jones, M.D. NPI is 1245291863. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: INDIANA UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1995
The provider's business location address is:
410 COLLEGE RD
GREENSBORO, NC
ZIP 27410-151
Phone: (336) 218-0994
Fax: (336) 218-0997
The NPI 1245291863 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Vitamin d-3 level (HCPCS:82306)
- Parathormone (parathyroid hormone) level (HCPCS:83970)
- Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Thyroid hormone, t3 measurement, total (HCPCS:84480)
- Thyroxine (thyroid chemical), free (HCPCS:84439)
- Hemoglobin a1c level (HCPCS:83036)
- Test to measure rate of airflow (HCPCS:94375)
- Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
- Blood glucose (sugar) test performed by hand-held instrument (HCPCS:82962)
- X-ray of chest, 2 views (HCPCS:71046)
- Urinalysis, manual test (HCPCS:81002)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
- Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
- Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
- Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
- Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Hepatitis c antibody measurement (HCPCS:86803)
- Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes (HCPCS:G0446)
- Hiv antigen/antibody, combination assay, screening (HCPCS:G0475)
The enumeration date for this NPI number is 3/31/2006 and was last updated on 7/19/2024.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207Q00000X | Family Medicine | | 9700302 | NORTH CAROLINA | No |
| 2 | 208VP0000X | Pain Medicine | Pain Medicine | 9700302 | NORTH CAROLINA | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 89127M8 | MEDICAID | NORTH CAROLINA | |
